FAS and Hepatic fibrosis: In summary, our investigation provides evidence that Fas/FasL contributes to NF-κBp65/PUMA-regulated hepatocytes apoptosis via autophagy to enhance HSCs activation and liver fibrosis, and this network could be a therapeutic target for liver fibrosis.